Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on baroreflex sensitivity in the absence of a gold standard.

[1]  F. Zeng,et al.  Associations between the severity of metabolic syndrome and cardiovascular autonomic function in a Chinese population , 2013, Journal of Endocrinological Investigation.

[2]  I A Gardner,et al.  Estimation of diagnostic-test sensitivity and specificity through Bayesian modeling. , 2005, Preventive veterinary medicine.

[3]  J. Mann,et al.  Diabetic Autonomic Neuropathy: the Prevalence of Impaired Heart Rate Variability in a Geographically Defined Population , 1989, Diabetic medicine : a journal of the British Diabetic Association.

[4]  Rodica Pop-Busui,et al.  Cardiac Autonomic Neuropathy in Diabetes , 2010, Diabetes Care.

[5]  M. Spüler,et al.  Prevalence of Cardiovascular Autonomic Dysfunction Assessed by Spectral Analysis, Vector Analysis, and Standard Tests of Heart Rate Variation and Blood Pressure Responses at Various Stages of Diabetic Neuropathy , 1992, Diabetic medicine : a journal of the British Diabetic Association.

[6]  Linuo Zhou,et al.  A risk score of cardiovascular autonomic dysfunction for targeted screening in the Chinese population. , 2013, International journal of cardiology.

[7]  A. Vinik,et al.  Diabetic Cardiovascular Autonomic Neuropathy , 2007, Circulation.

[8]  J. Schölmerich,et al.  Estimation of the cut-off value in cardiovascular autonomic nervous function tests: not-age-related criteria or the age-related 5th percentile. , 1997, Journal of diabetes and its complications.

[9]  R. Freeman,et al.  Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management , 2011, Diabetes/metabolism research and reviews.

[10]  D. Ewing,et al.  The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes , 1985, Diabetes Care.